Eduardo López-Collazo

6PUBLICATIONS
21CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersInfectious diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 16, 2025
Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients.

Jaime Valentín-Quiroga, Alejandro Zarauza-Santoveña, Eduardo López-Collazo

|Feb 01, 2023
The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification.

José Avendaño-Ortiz, Manuel Ponce-Alonso, Emilio Llanos-González

|May 11, 2022
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study.

Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Karla Montalbán-Hernández

|Oct 28, 2021
The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission.

José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós

|Jul 13, 2018
Obstructive Sleep Apnea Monocytes Exhibit High Levels of Vascular Endothelial Growth Factor Secretion, Augmenting Tumor Progression.

Carolina Cubillos-Zapata, Enrique Hernández-Jiménez, José Avendaño-Ortiz

Pageof 1